Ellenwood, GA, United States of America

Suazette Reid Mooring


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2020-2022

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Suazette Reid Mooring: Innovator in CXCR4 Inhibition

Introduction

Suazette Reid Mooring is a notable inventor based in Ellenwood, GA (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of bis-amine compounds related to CXCR4 inhibition. With a total of 2 patents, his work has the potential to impact the treatment of various diseases.

Latest Patents

Mooring's latest patents focus on bis-amines, compositions, and their uses related to CXCR4 inhibition. The disclosures detail bis-amine compounds and their applications in treating or preventing CXCR4-related diseases. In certain embodiments, the compounds are described with specific formulas, including salts, derivatives, and prodrugs. The patents also contemplate pharmaceutical compositions that incorporate these compounds, highlighting their therapeutic potential.

Career Highlights

Throughout his career, Suazette Reid Mooring has worked with esteemed institutions such as Emory University and Georgia State University Research Foundation, Inc. His research has contributed to advancements in the understanding and treatment of diseases associated with CXCR4.

Collaborations

Mooring has collaborated with notable colleagues, including Hyunsuk Shim and Renren Bai. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to impactful research outcomes.

Conclusion

Suazette Reid Mooring's work in the field of CXCR4 inhibition exemplifies the importance of innovation in pharmaceutical research. His contributions through patents and collaborations continue to pave the way for advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…